Albuquerque, NM, United States of America

Rodolfo Tello-Aburto


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Rodolfo Tello-Aburto

Introduction

Rodolfo Tello-Aburto is a notable inventor based in Albuquerque, New Mexico. He has made significant strides in the field of cancer research through his innovative work on proteasome inhibitors. His contributions are particularly relevant in the context of halting the proliferation of cancer cells.

Latest Patents

Tello-Aburto holds a patent for proteasome inhibitors. This patent discloses compounds that can prevent the degradation of cell cycle-regulating proteins, such as cyclins, cyclin-dependent kinase inhibitors, and p53. By inhibiting the proteasome, these compounds can effectively halt cell division in rapidly dividing cells, making them a potential therapeutic avenue for cancer treatment.

Career Highlights

He is affiliated with the New Mexico Tech University Research Park Corporation, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing scientific knowledge and developing practical applications for his inventions.

Collaborations

Tello-Aburto collaborates with esteemed colleagues, including Snezna Rogelj and Liam Hallada. These partnerships enhance the research environment and contribute to the innovative outcomes of their projects.

Conclusion

Rodolfo Tello-Aburto's work on proteasome inhibitors exemplifies the impact of innovation in cancer research. His contributions are paving the way for new therapeutic strategies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…